Gerresheimer reports double digit growth in revenue and earnings for the third quarter

• Organic revenue growth of 17.4% in the third quarter supported by continued sturdy demand for High Value Solutions
• Organic adjusted EBITDA up 13.3%
• Gerresheimer firmly on monitor to ship on FY 2022 steering

DUESSELDORF, Germany, Oct. 12, 2022 /PRNewswire/ —  Gerresheimer AG, a number one supplier of healthcare & magnificence options and drug supply methods for pharma, biotech and cosmetics, confirms steering for its monetary yr 2022 after one other quarter of sturdy and worthwhile growth. Revenue rose organically by 17.4% in the third quarter, reflecting sturdy buyer demand, main market positions and the ongoing success of its High Value Solutions. Adjusted EBITDA grew organically by 13.3%. “Gerresheimer continues on its profitable growth path across all our divisions, business segments and regions reflecting our strong market positions. While steering successfully through a challenging environment, we are consistently pursuing our growth strategy and are boosting our transformation process to become a solution provider and system integrator”, stated Dietmar Siemssen, CEO of Gerresheimer AG. “We are on track to deliver on our financial year 2022 guidance, and we are clearly committed to our mid-term targets”, he affirmed.

Press launch: https://www.gerresheimer.com/en/company/newsroom/corporate-news/detail/gerresheimer-reports-double-digit-growth-in-revenue-and-earnings-for-the-third-quarter

For additional info: http://www.presseportal.de/nr/9072/dokument?langid=2

Ueli Utzinger

Group Senior Director Marketing & Communication

T +49 211 6181-250

[email protected]

View unique content material:https://www.prnewswire.co.uk/news-releases/gerresheimer-reports-double-digit-growth-in-revenue-and-earnings-for-the-third-quarter-301646953.html

Source link